Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.

Kuroda H, Tamaru J, Takeuchi I, Ohnisi K, Sakamoto G, Adachi A, Kaneko K, Itoyama S.

Virchows Arch. 2006 Apr;448(4):500-5. Epub 2006 Mar 15.

PMID:
16538444
2.

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.

De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM.

J Pathol. 1997 Dec;183(4):404-11.

PMID:
9496256
4.

Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.

Goyal A, Martin TA, Mansel RE, Jiang WG.

World J Surg Oncol. 2008 Jun 11;6:56. doi: 10.1186/1477-7819-6-56.

5.

Expression of E-cadherin and catenins in invasive mammary carcinomas.

Zschiesche W, Schönborn I, Behrens J, Herrenknecht K, Hartveit F, Lilleng P, Birchmeier W.

Anticancer Res. 1997 Jan-Feb;17(1B):561-7.

PMID:
9066580
6.

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.

Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO.

J Pathol. 1999 Apr;187(5):523-9.

PMID:
10398116
7.

[E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast].

Han A, Xiong M, Li Z, Liang Y.

Zhonghua Bing Li Xue Za Zhi. 2001 Feb;30(1):27-30. Chinese.

PMID:
11866953
8.

The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast.

Dabbs DJ, Kaplai M, Chivukula M, Kanbour A, Kanbour-Shakir A, Carter GJ.

Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):260-6.

PMID:
17721269
9.

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL.

J Pathol. 1998 Jul;185(3):262-6.

PMID:
9771479
10.

E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.

Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL.

Mod Pathol. 2005 Jun;18(6):741-51.

11.

The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.

Dillon DA, D'Aquila T, Reynolds AB, Fearon ER, Rimm DL.

Am J Pathol. 1998 Jan;152(1):75-82.

12.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
13.

Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.

Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, Giannopoulou I, Keramopoulos A, Davaris P, Pignatelli M.

Histopathology. 2002 Jun;40(6):536-46.

PMID:
12047765
14.

c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.

Nakopoulou L, Gakiopoulou H, Keramopoulos A, Giannopoulou I, Athanassiadou P, Mavrommatis J, Davaris PS.

Histopathology. 2000 Apr;36(4):313-25.

PMID:
10759945
15.
16.

Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.

Kim HS, Kim GY, Kim YW, Park YK, Song JY, Lim SJ.

Histopathology. 2010 May;56(6):708-19. doi: 10.1111/j.1365-2559.2010.03534.x.

PMID:
20546336
17.

Aberrant expression of E-cadherin in lobular carcinomas of the breast.

Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, Clarke C, Lakhani SR, Simpson PT.

Am J Surg Pathol. 2008 May;32(5):773-83. doi: 10.1097/PAS.0b013e318158d6c5.

PMID:
18379416
18.

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.

Am J Clin Pathol. 2001 Jan;115(1):85-98.

19.

Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast.

Ellis PE, Cano SD, Fear M, Kelsell DP, Ghali L, Crow JC, Perrett CW, MacLean AB.

Mod Pathol. 2008 Oct;21(10):1192-9. doi: 10.1038/modpathol.2008.50. Epub 2008 May 9.

20.

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.

Rakha EA, Patel A, Powe DG, Benhasouna A, Green AR, Lambros MB, Reis-Filho JS, Ellis IO.

Am J Surg Pathol. 2010 Oct;34(10):1472-9. doi: 10.1097/PAS.0b013e3181f01916.

PMID:
20871222
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk